title: The influence of diabetes mellitus on the management and visual outcome of patients with uveitis.
authors: Moorfields Eye Hospital, London, UK; UCL Institute of Ophthalmology, London, UK.
authors: Lazha
authors: L
authors: Talat
authors: Oren
authors: O
authors: Tomkins-Netzer
authors: Simon R J
authors: SR
authors: Taylor
authors: Norshamsiah Md
authors: NM
authors: Din
authors: Asaf
authors: A
authors: Bar
authors: Hazlita
authors: H
authors: Isa
authors: Sue
authors: S
authors: Lightman
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002386:Cataract / Q000175:diagnosis; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000503:physiopathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008775:Methylprednisolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077555:Methylprednisolone Acetate; D011236:Prediabetic State / Q000175:diagnosis* / Q000503:physiopathology; D014222:Triamcinolone Acetonide / Q000627:therapeutic use; D014605:Uveitis / Q000188:drug therapy* / Q000503:physiopathology; D015354:Vision, Low / Q000175:diagnosis; D014792:Visual Acuity / Q000502:physiology*
chemical_list: D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D000077555:Methylprednisolone Acetate; D014222:Triamcinolone Acetonide; D008775:Methylprednisolone